Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Article Dans Une Revue European Radiology Année : 2017

Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey

Gérard de Geer
  • Fonction : Auteur
Gul Esen
  • Fonction : Auteur
Oswald Graf
  • Fonction : Auteur
Sylvia Heywang-Köbrunner
  • Fonction : Auteur
José Marques
  • Fonction : Auteur
  • PersonId : 1013342
Laura Martincich
  • Fonction : Auteur
Markus Müller-Schimpfle
  • Fonction : Auteur
Katalin Ormandi
  • Fonction : Auteur
Pietro Panizza
  • Fonction : Auteur
Federica Pediconi
  • Fonction : Auteur
Ruud Pijnappel
  • Fonction : Auteur
Katja Pinker
  • Fonction : Auteur
Tarja Rissanen
  • Fonction : Auteur
Natalia Rotaru
  • Fonction : Auteur
Gianni Saguatti
  • Fonction : Auteur
Tamar Sella
  • Fonction : Auteur
Jana Slobodníková
  • Fonction : Auteur
Maret Talk
  • Fonction : Auteur
Rubina Trimboli
  • Fonction : Auteur
Ilse Vejborg
  • Fonction : Auteur
Athina Vourtsis
  • Fonction : Auteur
Gabor Forrai
  • Fonction : Auteur

Résumé

EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1-10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40-49 years and 70-74 years, although with "limited evidence". Thus, we firstly recommend biennial screening mammography for average-risk women aged 50-69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40-45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become "routine mammography" in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged.

Dates et versions

hal-01806845 , version 1 (04-06-2018)

Identifiants

Citer

Francesco Sardanelli, Hildegunn Aase, Marina Álvarez, Edward Azavedo, Henk Baarslag, et al.. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. European Radiology, 2017, 27 (7), pp.2737 - 2743. ⟨10.1007/s00330-016-4612-z⟩. ⟨hal-01806845⟩
180 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More